Demant
Ty Lee currently serves as Group President for North America at Demant, a company specializing in hearing health innovation, and has been with the organization since November 2020. In addition, Ty holds the position of Independent Non-Executive Director on the Board of Optomed Plc and serves as Board Chair for Birdsong Hearing Benefits. Prior experience includes roles as Chief Marketing Officer at LifeScan, responsible for developing CGM technologies, and as Global SVP of Customer Strategy & Development at Johnson & Johnson, overseeing a $4.5 billion business. Ty also led the Americas as SVP & Commercial Head for Diabetes Companies. Ty holds a Master of Science from Northwestern University and an MBA from the University of California, Berkeley, Haas School of Business.
This person is not in any offices
Demant
15 followers
Demant is a world-leading hearing healthcare group that offers solutions and services to help people with hearing loss connect and communicate with the world around them. For more than a century, the Demant Group has played a vital part in developing innovative technologies and know-how to help improve people’s hearing and health. In every aspect, from hearing devices, hearing implants and diagnostic equipment to hearing care all over the world, Demant is active and engaged. The Demant Group operates in a global market with companies in more than 30 countries, employs more than 14,500 staff and generates annual revenue of DKK 14 billion. Our products are sold in more than 130 countries where we create life-changing differences through hearing health.